Form 8-K - Current report:
SEC Accession No. 0001628280-25-008163
Filing Date
2025-02-26
Accepted
2025-02-26 16:17:07
Documents
16
Period of Report
2025-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vir-20250226.htm   iXBRL 8-K 26538
2 EX-99.1 EARNINGS RELEASE a20250226-q4ex991earningsr.htm EX-99.1 137023
7 GRAPHIC virbiotechnologylogoa.jpg GRAPHIC 90295
  Complete submission text file 0001628280-25-008163.txt   463964

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vir-20250226.xsd EX-101.SCH 2139
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vir-20250226_def.xml EX-101.DEF 15302
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vir-20250226_lab.xml EX-101.LAB 26870
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vir-20250226_pre.xml EX-101.PRE 16021
18 EXTRACTED XBRL INSTANCE DOCUMENT vir-20250226_htm.xml XML 3339
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

EIN.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 25670301
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)